Ischemia-modified albumin for the assessment of myocardial ischemia in patients with hypovolemia

Xinyan Zhang,Xuezhong Yu
DOI: https://doi.org/10.15932/j.0253-9713.2014.07.003
2014-01-01
Abstract:Objective To evaluate the utilization of ischemia-modified albumin (IMA) in early diagnosis of myocardial ischemia caused by hypovolemia in gastrointestinal bleeding patients. Methods This case-controlled study was conducted in the emergency department of Peking Union Medical College Hospital from December 2008 to March 2009. Thirty patients presenting with gastrointestinal hemorrhage and 20 healthy subjects were enrolled. Serum sam-ples were tested for albumin-cobalt binding (ACB), albumin and hemoglobin. IMA was inversely proportional to ACB. All patients had the electrocardiogram (ECG) tested. The ACB levels in the two groups and correlations with other parameters were compared. Results Serum ACB levels were significantly lower in patients group compared with the controls (57.8± 9.06 U/ml versus 75.2 ±4.20 U/ml; P< 0.001). while IMA was significantly higher in the patient group. At the cutoff of 67.15 U/ml, ROC curve analysis showed that the sensitivity, specificity, positive predictive value and the negative predic-tive value of ACB was 86.4%, 75.0%, 73.1%, and 87.5% respectively. Its total consistent rate with ECG was 80%. Con-clusion IMA may serve as a useful diagnostic tool in early diagnosis of myocardial ischemia in gastrointestinal bleeding patients. IMA could be utilized for the assessment of myocardial ischemia because of its high sensitivity and negative pre-dictive value.
What problem does this paper attempt to address?